NVIDIA Webinar
Date: Thursday, February 15, 2024
Time: 10:00 –11:00 a.m. PT
Duration: 1 hour
Time: 10:00 –11:00 a.m. PT
Duration: 1 hour
Pharmaceutical researchers are continually on the quest for better, faster ways to design drugs, but juggling independently designed software and data sources has created a long-standing challenge. NVIDIA and OneAngstrom have collaborated to reduce this fragmentation.
Join the discussion and see how molecular design is more accessible than ever before.
In this webinar you will learn:
- Integrative molecular modeling results in streamlined, state-of-the-art workflows for scientists
- To access NVIDIA BioNeMo™ in just a few clicks to predict protein structures and dock libraries of ligands directly
- To combine BioNeMo with all other extensions available in SAMSON for modeling, simulation, analysis, visualization, scripting, and more
Webinar Registration
By filling out the form, you agree to share your data with our partner, OneAngstrom. Your information will be handled in accordance with OneAngstrom's Privacy Policy.
THANK YOU FOR REGISTERING FOR THE WEBINAR
You will receive an email with instructions on how to join the webinar shortly.
Main Content
maincontent goes here
Content
Content goes here
Content
content goes here
Content
Content goes here
Content
DGX Station Whitepaper
Dive deeper into the DGX Station and learn more about the architecture, NVLink, frameworks, tools and more.
Dive deeper into the DGX Station and learn more about the architecture, NVLink, frameworks, tools and more.
DGX Station Whitepaper
Dive deeper into the DGX Station and learn more about the architecture, NVLink, frameworks, tools and more.
Dive deeper into the DGX Station and learn more about the architecture, NVLink, frameworks, tools and more.
DGX Station Whitepaper
Dive deeper into the DGX Station and learn more about the architecture, NVLink, frameworks, tools and more.
Dive deeper into the DGX Station and learn more about the architecture, NVLink, frameworks, tools and more.
Content
Content goes here
Speakers
David Ruau
Head of Strategic Alliances, Drug Discovery AI, EMEA, NVIDIADavid is an experienced leader in the healthcare and life sciences industry. David is heading the strategic scientific partnership in healthcare and life sciences across EMEA at NVIDIA. Prior to that, he was chief scientific officer at a healthcare AI company, VP of global data assets and decision science at Bayer pharmaceuticals, and head of scientific computing at AstraZeneca. David's academic background is in computational biology analyzing IPS cells reprogramming and patient medical information in different therapeutic areas. David has authored 30+ peer-reviewed publications and book chapters in journals like Nature, Cell, and Stem Cells.
Stephane Redon, PhD
CEO and Co-founder, OneAngstromStephane Redon is co-founder and CEO of OneAngstrom, the developers of the SAMSON platform for molecular design. Until September 2018, Stephane was a senior researcher at Inria and the leader of the NANO-D group that he started in 2008 to develop algorithms for nanoscience. His research has been funded by Inria, Advanced Nano Research (ANR), and the European Research Council. He has been teaching at Ecole Polytechnique in Paris since 2005, where he's still a part-time professor. He’s the principal architect and lead developer of the SAMSON software platform for molecular modeling.
Presenter 3 Name
Presenter 3 TitlePresenter 3 Bio
Presenter 4 Name
Job Title 4Presenter 4 Bio
Main CTA for lightbox form use class="lightbox" CTA
Content Title
Content here
Register
Webinar: Description here
Date & Time: Wednesday, April 22, 2018